Developer docs
API playgroundTry for free, no card

Search company profiles

Sonic Clinical Trials

Full company profile

uuid0022i6s

Namestring
Sonic Clinical Trials
Legal namestring
Sonic Clinical Trials Pty Ltd
Company typeenum
Private
Founded yearint
1994
Descriptiontext

Sonic Clinical Trials (SCT) is a central laboratory services provider dedicated to supporting Phase I-IV clinical trials and safety testing for pharmaceutical, biotechnology, CRO, and medical device sponsors worldwide. Founded in 1994 as a division of Sonic Healthcare and operating under the legal entity Sonic Clinical Trials Pty Ltd, the company runs owned central laboratories in Sydney, Austin, Antwerp, and London, and leverages Sonic Healthcare's Australian diagnostic network (Sydney, Melbourne, Brisbane, Adelaide, Perth) for local laboratory services. Its service portfolio spans routine and esoteric testing (biochemistry, haematology, microbiology, endocrinology, molecular biology, pharmacogenomics, biomarker analysis), sample management with cold chain logistics, kit production and automatic resupply, project management, and data management. The technology backbone consists of the proprietary Artemis Laboratory Information Management System (LIMS) for managing kits, logistics, sample analysis, blinding, and reference ranges, integrated with the Sonic Realtime digital portal for near real-time, browser-based study data access. The company is an accredited Research Service Provider under the Australian R&D Tax Incentive program, allowing eligible clients to claim up to 45% R&D tax offsets.

The business operates as a B2B enterprise with quote-based, multi-year contracted service agreements tailored to study complexity, volume, and geographic scope. Go-to-market relies on direct enterprise sales through a dedicated business development function, supplemented by participation in major industry events (BIO International, DIA Global, ARCS, Outsourcing in Clinical Trials Europe, Knowledge For Growth). Revenue is not publicly disclosed. SCT maintains a broad portfolio of accreditations (NATA ISO/IEC 17025, CAP, CMS/CLIA, NGSP, CDC Lipid Standardisation, UKAS, FDA 21 CFR Part 11, TGA, ICH GCP) that serve as a core competitive barrier, while benefiting from the global infrastructure, capital access, and brand of its publicly listed parent, Sonic Healthcare, which ranks in the top 50 on the ASX and serves more than 100 million patients annually.

Short descriptiontext

Sonic Clinical Trials is a global central laboratory services provider supporting Phase I-IV clinical trials and safety testing for pharmaceutical, biotechnology, CRO, and medical device sponsors, operating from four central labs and the Sonic Healthcare diagnostic network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSydney, Australia
HQ citystring
Sydney
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
central laboratory services, clinical trial testing, safety testing services, pharmaceutical laboratory services, biomarker analysis services
Industry5 codes
PRIMARYHLAGAEAK
Point-of-Care & Decentralized Trial Testing Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGADAA
Bioanalytical Testing (PK/ADA/NAb)
SECONDARYHLAFAMAJ
Reference & Esoteric Testing Laboratories
SECONDARYHLAIALAE
Clinical Development (Phase I–III Trial Design & Execution)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Trial Laboratory Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Central Laboratory Services
TypeProfessional Services
Description

Sonic Clinical Trials generates revenue through providing comprehensive central laboratory testing services to pharmaceutical, biotech, and CRO clients conducting clinical trials. Services include routine and esoteric testing, sample management, kit production, logistics, and data management. Revenue is derived from contracted service agreements for Phase I-IV clinical trials.

sonicclinicaltrials.com.au
2Research Service Provider (RSP)
TypeLicensing Royalties
Description

As an accredited Research Service Provider under the Australian Government's R&D Tax Incentive program, SCT enables eligible companies to claim R&D tax offsets for expenditure on registered R&D activities conducted by SCT.

sonicclinicaltrials.com.au
3Local Laboratory Services
TypeProfessional Services
Description

Provides flexible local laboratory data solutions using Australia's largest diagnostic laboratory network (Sydney, Melbourne, Brisbane, Adelaide, Perth) for faster, more streamlined patient data management particularly in early-phase and acute care studies.

sonicclinicaltrials.com.au
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Enterprise B2B service contracts for pharmaceutical and biotech clients
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing structured through contracted service agreements based on study complexity, volume, geographic scope, and specific testing requirements. No public pricing tiers available.

sonicclinicaltrials.com.au
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Sonic Realtime
Description

Digital e-request solution providing continuous access to study data and patient lab results through a secure online portal.

sonicclinicaltrials.com.au
Core offering1 text field

Sonic Clinical Trials (SCT) is a global central laboratory that provides comprehensive testing, sample management, kit production, logistics, and data management services exclusively for Phase I-IV clinical trials. It serves pharmaceutical, biotechnology, and contract research organisations with central laboratory services backed by proprietary Artemis LIMS and the Sonic Realtime digital portal, plus local laboratory services delivered through Sonic Healthcare's diagnostic network.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • ~95% of laboratory testing performed within Sonic group of laboratories
+1 more record
Product overview1 text field

Sonic Clinical Trials provides comprehensive central laboratory services for Phase I-IV clinical trials and safety testing for pharmaceutical, biotechnology, and research organisations worldwide. The core technology platform consists of the Artemis LIMS for integrated laboratory information management, complemented by the Sonic Realtime® digital platform for real-time data access and reporting. Their service portfolio encompasses laboratory services (biochemistry, haematology, microbiology, immuoserology, endocrinology, drug screening, cytology, molecular biology, histology, pharmacogenomics, biomarker analysis), scientific affairs, sample management with cold chain storage capabilities, kit production and logistics with automatic resupply, site support and project management, data management with validated electronic systems, quality assurance, and Research Service Provider services. Additionally, a dedicated Local Laboratory and Special Projects division provides flexible local laboratory data solutions and specialized services including Phase 1 local laboratory services, acute care studies, biomarker development, specialty sample processing, diagnostics-to-market support, and custom biorepository services.

Product and service5 records
1Central Laboratory Services
CategoryClinical Trial Central Laboratory Services
Description

Comprehensive central laboratory testing and support services for Phase I-IV clinical trials, including routine and esoteric testing (biochemistry, haematology, microbiology, immuneserology, endocrinology, drug screening, cytology, molecular biology, histology, pharmacogenomics, biomarker analysis), sample management, kit production, logistics, site support, project management, and data management. Delivered to pharmaceutical, biotechnology, and CRO clients globally through central laboratories in Sydney, Austin, Antwerp, and London.

2Local Laboratory Services
CategoryLocal Clinical Trial Laboratory Services
Description

Flexible local laboratory data solutions provided through Sonic Healthcare's Australian diagnostic network (Sydney, Melbourne, Brisbane, Adelaide, Perth). Designed for early-phase and acute care studies requiring faster, more streamlined patient data management with seamless integration to central laboratory data.

3Special Projects
CategorySpecialized Clinical Trial Laboratory Services
Description

Specialized clinical trial laboratory services including biomarker development, specialty sample processing, diagnostics-to-market support, custom biorepository services, and Phase 1 and acute care study support. Targeted at clients with bespoke or non-standard trial requirements.

4Research Service Provider (RSP) Services
CategoryResearch and Development Tax Incentive Services
Description

Accredited Research Service Provider services under the Australian Government's R&D Tax Incentive program, enabling eligible companies to claim R&D tax offsets (up to 45%) for eligible expenditure on registered R&D activities conducted by Sonic Clinical Trials.

5Sonic Realtime
CategoryClinical Trial Data Management Platform
Description

Digital e-request solution providing continuous, near real-time access to study data and patient lab results through any major web browser. Integrated with Artemis LIMS, with study-specific reference ranges, alerts, and data blinding, secured by 128-bit SSL encryption. Provided to enterprise clinical trial clients as part of SCT's central laboratory services.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Sonic Clinical Trials is a wholly owned subsidiary of Sonic Healthcare, one of the world's largest specialist medical diagnostics companies. This parent company relationship provides SCT with access to global laboratory infrastructure, diagnostic resources, medical expertise, and the extensive Sonic Healthcare network of laboratories across Australia, USA, Germany, Switzerland, UK, Belgium, and New Zealand.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

ACM Global Laboratories is an independent central lab providing Phase I–IV safety testing, biomarker and specialty testing with operations across the US, UK, Europe, India, and Singapore. Its focus on safety testing and central lab services for global trials makes it a direct peer to SCT.

2Boca Biolistics / reference lab niche players
TypeEmerging player
Description

Niche specialty reference laboratories focused on bioanalytical, specialty biomarker, and esoteric testing services overlap with SCT's specialty/PK/biomarker testing capabilities, often addressing similar biotech customers with narrower specialty menus.

TypeDirect peer
Description

Eurofins Central Laboratory operates end-to-end central lab services for Phase I–IV clinical trials across multiple continents with harmonized SOPs, kit production, and logistics — directly comparable to SCT's central laboratory service model across pharma, biotech, and CRO customers.

TypeBroad incumbent
Description

Medpace is a mid-sized global CRO with embedded laboratory and biomarker services supporting biotech and small-mid pharma sponsors across Phase I–IV trials — comparable to SCT in customer profile and trial phase coverage, though central lab is one component of a broader CRO model.

TypeDirect peer
Description

Fortrea (the clinical development business spun out from LabCorp Drug Development) operates central laboratory, bioanalytical, and biomarker services integrated with broader CRO functions — directly competitive with SCT for global pharma/biotech central lab contracts.

TypeDirect peer
Description

Q² Solutions is a central laboratory joint venture between IQVIA and Quest Diagnostics that provides safety, biomarker, bioanalytical, and genomic lab services for clinical trials. It is the closest comparable to SCT given its global multi-region central lab footprint, biomarker and PK/PD testing, and direct competition for pharma/biotech/CRO sponsors.

TypeEmerging player
Description

Worldwide Clinical Trials is a mid-sized CRO with bioanalytical and central lab capabilities serving small to mid-sized pharma/biotech sponsors across rare disease and specialty therapy areas — a partial-overlap peer to SCT on the central lab side of clinical trial support.

TypeBroad incumbent
Description

PPD's clinical research services, now part of Thermo Fisher, include central laboratory and bioanalytical operations supporting global clinical trials. Comparable to SCT in central lab capabilities but bundled within a much larger CRO and life sciences tools platform.

TypeBroad incumbent
Description

ICON is one of the largest global CROs with embedded central laboratory and bioanalytical capabilities serving similar pharma and biotech customers across Phase I–IV trials. It competes with SCT primarily via its broader CRO-service bundling, even though central lab work is one piece of a much wider portfolio.

TypeOthers
Description

Sonic Healthcare is the parent company of SCT. While not a peer in the competitive sense, its broader diagnostic pathology network underpins SCT's local lab service capabilities and represents the most operationally intertwined comparable in the diagnostic-central lab space.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance10 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sonic Clinical Trials

Clinical Trial Laboratory Servicessonicclinicaltrials.com.au

Sonic Clinical Trials is a global central laboratory services provider supporting Phase I-IV clinical trials and safety testing for pharmaceutical, biotechnology, CRO, and medical device sponsors, operating from four central labs and the Sonic Healthcare diagnostic network.

What Sonic Clinical Trials does

Sonic Clinical Trials (SCT) is a central laboratory services provider dedicated to supporting Phase I-IV clinical trials and safety testing for pharmaceutical, biotechnology, CRO, and medical device sponsors worldwide. Founded in 1994 as a division of Sonic Healthcare and operating under the legal entity Sonic Clinical Trials Pty Ltd, the company runs owned central laboratories in Sydney, Austin, Antwerp, and London, and leverages Sonic Healthcare's Australian diagnostic network (Sydney, Melbourne, Brisbane, Adelaide, Perth) for local laboratory services. Its service portfolio spans routine and esoteric testing (biochemistry, haematology, microbiology, endocrinology, molecular biology, pharmacogenomics, biomarker analysis), sample management with cold chain logistics, kit production and automatic resupply, project management, and data management. The technology backbone consists of the proprietary Artemis Laboratory Information Management System (LIMS) for managing kits, logistics, sample analysis, blinding, and reference ranges, integrated with the Sonic Realtime digital portal for near real-time, browser-based study data access. The company is an accredited Research Service Provider under the Australian R&D Tax Incentive program, allowing eligible clients to claim up to 45% R&D tax offsets.

The business operates as a B2B enterprise with quote-based, multi-year contracted service agreements tailored to study complexity, volume, and geographic scope. Go-to-market relies on direct enterprise sales through a dedicated business development function, supplemented by participation in major industry events (BIO International, DIA Global, ARCS, Outsourcing in Clinical Trials Europe, Knowledge For Growth). Revenue is not publicly disclosed. SCT maintains a broad portfolio of accreditations (NATA ISO/IEC 17025, CAP, CMS/CLIA, NGSP, CDC Lipid Standardisation, UKAS, FDA 21 CFR Part 11, TGA, ICH GCP) that serve as a core competitive barrier, while benefiting from the global infrastructure, capital access, and brand of its publicly listed parent, Sonic Healthcare, which ranks in the top 50 on the ASX and serves more than 100 million patients annually.

Sonic Clinical Trials firmographics

Firmographics
Name
Sonic Clinical Trials
Legal name
Sonic Clinical Trials Pty Ltd
Website
https://sonicclinicaltrials.com.au
Company type
Private
Founded year
1994
Operating status
Operating
Headcount range
51–100 employees
Short description
Sonic Clinical Trials is a global central laboratory services provider supporting Phase I-IV clinical trials and safety testing for pharmaceutical, biotechnology, CRO, and medical device sponsors, operating from four central labs and the Sonic Healthcare diagnostic network.
Ownership category
akta.pro rank

Sonic Clinical Trials industry classification

Industry
Product category
Clinical Trial Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGAEAK
Point-of-Care & Decentralized Trial Testing Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAAMAC
Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
SECONDARYHLAGADAA
Bioanalytical Testing (PK/ADA/NAb)
SECONDARYHLAFAMAJ
Reference & Esoteric Testing Laboratories
SECONDARYHLAIALAE
Clinical Development (Phase I–III Trial Design & Execution)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development

Keywords

  • Central laboratory services
  • Clinical trial testing
  • Safety testing services
  • Pharmaceutical laboratory services
  • Biomarker analysis services

Where Sonic Clinical Trials is headquartered

Location

Headquarters

HQ city
Sydney
HQ country
Australia
HQ region
Oceania

Offices8 records

Markets served

Sonic Clinical Trials business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Central Laboratory Services: Sonic Clinical Trials generates revenue through providing comprehensive central laboratory testing services to pharmaceutical, biotech, and CRO clients conducting clinical trials. Services include routine and esoteric testing, sample management, kit production, logistics, and data management. Revenue is derived from contracted service agreements for Phase I-IV clinical trials.
  2. Research Service Provider (RSP): As an accredited Research Service Provider under the Australian Government's R&D Tax Incentive program, SCT enables eligible companies to claim R&D tax offsets for expenditure on registered R&D activities conducted by SCT.
  3. Local Laboratory Services: Provides flexible local laboratory data solutions using Australia's largest diagnostic laboratory network (Sydney, Melbourne, Brisbane, Adelaide, Perth) for faster, more streamlined patient data management particularly in early-phase and acute care studies.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise B2B service contracts for pharmaceutical and biotech clients

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Sonic Clinical Trials product offering

Product offering

Core offering

Sonic Clinical Trials (SCT) is a global central laboratory that provides comprehensive testing, sample management, kit production, logistics, and data management services exclusively for Phase I-IV clinical trials. It serves pharmaceutical, biotechnology, and contract research organisations with central laboratory services backed by proprietary Artemis LIMS and the Sonic Realtime digital portal, plus local laboratory services delivered through Sonic Healthcare's diagnostic network.

Product overview

Sonic Clinical Trials provides comprehensive central laboratory services for Phase I-IV clinical trials and safety testing for pharmaceutical, biotechnology, and research organisations worldwide. The core technology platform consists of the Artemis LIMS for integrated laboratory information management, complemented by the Sonic Realtime® digital platform for real-time data access and reporting. Their service portfolio encompasses laboratory services (biochemistry, haematology, microbiology, immuoserology, endocrinology, drug screening, cytology, molecular biology, histology, pharmacogenomics, biomarker analysis), scientific affairs, sample management with cold chain storage capabilities, kit production and logistics with automatic resupply, site support and project management, data management with validated electronic systems, quality assurance, and Research Service Provider services. Additionally, a dedicated Local Laboratory and Special Projects division provides flexible local laboratory data solutions and specialized services including Phase 1 local laboratory services, acute care studies, biomarker development, specialty sample processing, diagnostics-to-market support, and custom biorepository services.

Differentiator

Problem solved

Functional benefit

Brands

  • Sonic Realtime: Digital e-request solution providing continuous access to study data and patient lab results through a secure online portal.

Products and services

  • Central Laboratory Services Comprehensive central laboratory testing and support services for Phase I-IV clinical trials, including routine and esoteric testing (biochemistry, haematology, microbiology, immuneserology, endocrinology, drug screening, cytology, molecular biology, histology, pharmacogenomics, biomarker analysis), sample management, kit production, logistics, site support, project management, and data management. Delivered to pharmaceutical, biotechnology, and CRO clients globally through central laboratories in Sydney, Austin, Antwerp, and London.
  • Local Laboratory Services Flexible local laboratory data solutions provided through Sonic Healthcare's Australian diagnostic network (Sydney, Melbourne, Brisbane, Adelaide, Perth). Designed for early-phase and acute care studies requiring faster, more streamlined patient data management with seamless integration to central laboratory data.
  • Special Projects Specialized clinical trial laboratory services including biomarker development, specialty sample processing, diagnostics-to-market support, custom biorepository services, and Phase 1 and acute care study support. Targeted at clients with bespoke or non-standard trial requirements.
  • Research Service Provider (RSP) Services Accredited Research Service Provider services under the Australian Government's R&D Tax Incentive program, enabling eligible companies to claim R&D tax offsets (up to 45%) for eligible expenditure on registered R&D activities conducted by Sonic Clinical Trials.
  • Sonic Realtime Digital e-request solution providing continuous, near real-time access to study data and patient lab results through any major web browser. Integrated with Artemis LIMS, with study-specific reference ranges, alerts, and data blinding, secured by 128-bit SSL encryption. Provided to enterprise clinical trial clients as part of SCT's central laboratory services.

Quantifiable outcome

  • ~95% of laboratory testing performed within Sonic group of laboratories
  • +1 more outcomes

Companies that use Sonic Clinical Trials

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Sonic Clinical Trials technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Sonic Clinical Trials partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Sonic HealthcarecoreOthersSonic Clinical Trials is a wholly owned subsidiary of Sonic Healthcare, one of the world's largest specialist medical diagnostics companies. This parent company relationship provides SCT with access to global laboratory infrastructure, diagnostic resources, medical expertise, and the extensive Sonic Healthcare network of laboratories across Australia, USA, Germany, Switzerland, UK, Belgium, and New Zealand.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Sonic Clinical Trials competitors and assessment

Company assessment

Direct peers

  • ACM Global Laboratories: ACM Global Laboratories is an independent central lab providing Phase I–IV safety testing, biomarker and specialty testing with operations across the US, UK, Europe, India, and Singapore. Its focus on safety testing and central lab services for global trials makes it a direct peer to SCT.
  • Eurofins Central Laboratory: Eurofins Central Laboratory operates end-to-end central lab services for Phase I–IV clinical trials across multiple continents with harmonized SOPs, kit production, and logistics — directly comparable to SCT's central laboratory service model across pharma, biotech, and CRO customers.
  • LabCorp Drug Development (Fortrea): Fortrea (the clinical development business spun out from LabCorp Drug Development) operates central laboratory, bioanalytical, and biomarker services integrated with broader CRO functions — directly competitive with SCT for global pharma/biotech central lab contracts.
  • Q² Solutions: Q² Solutions is a central laboratory joint venture between IQVIA and Quest Diagnostics that provides safety, biomarker, bioanalytical, and genomic lab services for clinical trials. It is the closest comparable to SCT given its global multi-region central lab footprint, biomarker and PK/PD testing, and direct competition for pharma/biotech/CRO sponsors.

Emerging players

  • Boca Biolistics / reference lab niche players: Niche specialty reference laboratories focused on bioanalytical, specialty biomarker, and esoteric testing services overlap with SCT's specialty/PK/biomarker testing capabilities, often addressing similar biotech customers with narrower specialty menus.
  • Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized CRO with bioanalytical and central lab capabilities serving small to mid-sized pharma/biotech sponsors across rare disease and specialty therapy areas — a partial-overlap peer to SCT on the central lab side of clinical trial support.

Broad incumbents

  • Medpace: Medpace is a mid-sized global CRO with embedded laboratory and biomarker services supporting biotech and small-mid pharma sponsors across Phase I–IV trials — comparable to SCT in customer profile and trial phase coverage, though central lab is one component of a broader CRO model.
  • PPD (Thermo Fisher Scientific): PPD's clinical research services, now part of Thermo Fisher, include central laboratory and bioanalytical operations supporting global clinical trials. Comparable to SCT in central lab capabilities but bundled within a much larger CRO and life sciences tools platform.
  • ICON plc (formerly PRA Health/CRL Clinical): ICON is one of the largest global CROs with embedded central laboratory and bioanalytical capabilities serving similar pharma and biotech customers across Phase I–IV trials. It competes with SCT primarily via its broader CRO-service bundling, even though central lab work is one piece of a much wider portfolio.

Others

  • Sonic Healthcare (parent): Sonic Healthcare is the parent company of SCT. While not a peer in the competitive sense, its broader diagnostic pathology network underpins SCT's local lab service capabilities and represents the most operationally intertwined comparable in the diagnostic-central lab space.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Sonic Clinical Trials social profiles

Digital presence

Sonic Clinical Trials compliance and trust

Trust signal

Compliance10 records

Sonic Clinical Trials financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sonic Clinical Trials leadership team

Management profile

Number of profiles

Profiles12 records

Sonic Clinical Trials funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sonic Clinical Trials M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sonic Clinical Trials

What does Sonic Clinical Trials do?

Sonic Clinical Trials (SCT) is a global central laboratory that provides comprehensive testing, sample management, kit production, logistics, and data management services exclusively for Phase I-IV clinical trials. It serves pharmaceutical, biotechnology, and contract research organisations with central laboratory services backed by proprietary Artemis LIMS and the Sonic Realtime digital portal, plus local laboratory services delivered through Sonic Healthcare's diagnostic network.

Is Sonic Clinical Trials a public or private company?

Sonic Clinical Trials is a private company. It is classified as corporate owned and is currently operating.

When was Sonic Clinical Trials founded?

Sonic Clinical Trials was founded in 1994. It employs 51 to 100 people.

Where is Sonic Clinical Trials based?

Sonic Clinical Trials is headquartered in Sydney, Australia, in the Oceania region.

How does Sonic Clinical Trials make money?

Three revenue lines are on record. Central Laboratory Services are the primary driver. The others are research Service Provider (RSP) and local Laboratory Services.

Who are Sonic Clinical Trials's main competitors?

Direct peers on record are ACM Global Laboratories, Eurofins Central Laboratory, LabCorp Drug Development (Fortrea) and Q² Solutions. Emerging players are Boca Biolistics / reference lab niche players and Worldwide Clinical Trials. Broad incumbents are Medpace, PPD (Thermo Fisher Scientific) and ICON plc (formerly PRA Health/CRL Clinical). Sonic Healthcare (parent) is listed as an others.

Does Sonic Clinical Trials have an API?

No public API is recorded for Sonic Clinical Trials.

What industry is Sonic Clinical Trials in?

Sonic Clinical Trials's product category is Clinical Trial Laboratory Services. Its primary akta.pro industry code is HLAGAEAK, Point-of-Care & Decentralized Trial Testing Services, with a secondary code of HLAAAMAC, Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales